Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses-Reference-Cited by-同舟云学术

Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses

Published:2017-03-02 Issue:3 Volume:12 Page:e0172512
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Friedman Deborah,Fryzek Jon,Jiang Xiaohui,Bloomfield Adam,Ambrose Christopher S.,Wong Pierre C.

Funder

AstraZeneca

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice;BA Paes;Can Respir J,2011

2. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997–2006;LJ Stockman;Pediatr Infect Dis J,2012

3. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age;CB Hall;Pediatrics,2013

4. Epidemiology and prevention of respiratory syncytial virus infections among infants and young children;GF Langley;Pediatr Infect Dis J,2011

5. Respiratory tract infection and risk of hospitalization in children with congenital heart defects during season and off-season: a Swedish national study;E Granbom;Pediatr Cardiol,2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hospital Outcomes Among Children With Congenital Heart Disease and Adenovirus Pneumonia;Pediatric Infectious Disease Journal;2024-04-02

2. An epidemiological investigation of high-risk infants for Respiratory Syncytial Virus infections: a retrospective cohort study;Italian Journal of Pediatrics;2024-03-25

3. Impact of congenital heart disease on mortality and other associated outcomes in children hospitalised for acute asthma exacerbation;Cardiology in the Young;2023-11-10

4. Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection;Pediatrics;2023-06-26

5. La profilassi dell’infezione da virus respiratorio sinciziale: dal palivizumab al nirsevimab;Medico e Bambino;2022-12-21